Role of pHyde novel gene product as an intrinsic factor for apoptotic pathway in prostate cancer.
Role of pHyde novel gene product as an intrinsic factor for apoptotic pathway in prostate cancer.
复制标题
DOI:
--
复制
发表时间:
2000-05
期刊:
影响因子:
--
通讯作者:
A. Rinaldy;R. Menon;J. Lerner;M. Steiner
中科院分区:
文献类型:
--
作者:
A. Rinaldy;R. Menon;J. Lerner;M. Steiner
Induction of apoptotic cell death mechanism can be regulated by internal factor(s), such as by gene product(s) that directly upregulate the apoptosis pathway or indirectly by down-regulating the anti-apoptosis gene. This homeostasis is a normal phenomenon in a biological system disturbed by cancer. It is thus important to find any gene functioning as an upregulator for the apoptosis pathway that may have a potential application in the context of cancer gene therapy. We have cloned a novel rat gene, denoted as pHyde, that fulfilled this objective. Internally, this pHyde gene product renders the stable transfectant of rat prostatic cancer cell lines more susceptible to apoptosis even without any external inducer. By using an external agent, such as 5-fluoro-2'-deoxyuridine (FdUr), apoptotic responses of the stable transfectants are even higher, suggesting that both intrinsic and extrinsic factors work synergistically. The pHyde gene product was termed an intrinsic factor, whereas FdUr was considered an extrinsic factor for the apoptosis in rat prostate cancer model.